Margaret Grohne ('58) knows firsthand the importance of mitigating, preventing and eradicating cancer. She is a breast cancer survivor, and her sister and brother-in-law lost their lives to cancer.

She and her husband, David ('58), also know firsthand the value of a CU education. They met in high school and attended CU-Boulder in the 1950s. While they now live in the Midwest, they've been long-time supporters of numerous CU programs including the University of Colorado Cancer Center (UCCC).

In recognition of the center's research track record and potential for significant discoveries, the Grohnes recently pledged more than $2.6 million to support research in the areas of breast cancer, stem cell research and cancer vaccinations.

"The Grohnes want to support high-quality research here in Colorado, and they've been incredibly generous to us," said Andrew Thorburn, Ph.D., UCCC interim director.

Federal grants for medical research most often fund research in later stages of development. For exploration in more cutting-edge realms, it can be hard to obtain grants. Yet in such areas, many of the most promising lines of inquiry are being pursued. Early stage research is far more dependent on private donors, whose gifts can have a multiplier effect when such seed funding leads to federal research grants down the road.

The Grohnes' generosity is further enhanced because they are unrestricted research funds, increasing the Center's flexibility.

"These sorts of gifts are the lifeblood that keep the Cancer Center going," Thorburn said.

Margaret Grohne says her biggest motivation for the gift was to give back to the university that has given her and her husband so much, and to conquer the devastating disease.

"We all are looking for a cure," she said.